FDA Brief

Company record

Boiron, Inc.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Boiron, Inc..

Warning letters

  1. Boiron, Inc.

    FDA warns Boiron that Optique 1 Eye Drops are an unapproved new drug sold with drug claims.

    High risk